tetano
Editor, Senior Moderator
Vaccine
. 2025 Nov 6:68:127945.
doi: 10.1016/j.vaccine.2025.127945. Online ahead of print. Provider setting for influenza and COVID-19 vaccination among Australian adults in 2023 and 2024
Joanne Reekie[SUP] 1 [/SUP], Sandrine Stepien[SUP] 2 [/SUP], Alexandra Hendry[SUP] 2 [/SUP], Lauren Dalton[SUP] 2 [/SUP], Kristine Macartney[SUP] 3 [/SUP], Bette Liu[SUP] 4 [/SUP]
Affiliations
Objectives: Australia expanded access to funded pharmacy vaccination in 2024. We examined changes in the proportion of adult pharmacy-administered vaccination.
Methods: Adult influenza and COVID-19 vaccinations reported in the Australian Immunisation Register from 2023 to 2024 linked to Australian Census socio-demographic information were assessed.
Results: In 2023, 61% of 7.49 million influenza and 54% of 4.61 million COVID-19 vaccinations were provided in general practices, compared to 24% and 44%, respectively, in pharmacies. While total vaccinations declined in 2024 (influenza: 7.04 million; COVID-19: 2.48 million) there was a small increase in pharmacy-administered influenza vaccinations (adjusted odds ratio 1.16 95%CI 1.16-1.17). In both years, a lower proportion of pharmacy-administered vaccinations were given to adults: aged ≥65 years (vs. <65 years); from culturally and linguistically diverse(CALD) backgrounds (vs. non-CALD); with lower incomes, employment and education (vs. higher).
Conclusion: Expanding pharmacy provision of vaccinations may improve uptake, but understanding the impact on under-vaccinated populations is needed.
Keywords: COVID-19; General practice; Influenza; Pharmacy; Vaccination; Vaccine
. 2025 Nov 6:68:127945.
doi: 10.1016/j.vaccine.2025.127945. Online ahead of print. Provider setting for influenza and COVID-19 vaccination among Australian adults in 2023 and 2024
Joanne Reekie[SUP] 1 [/SUP], Sandrine Stepien[SUP] 2 [/SUP], Alexandra Hendry[SUP] 2 [/SUP], Lauren Dalton[SUP] 2 [/SUP], Kristine Macartney[SUP] 3 [/SUP], Bette Liu[SUP] 4 [/SUP]
Affiliations
- PMID: 41202610
- DOI: 10.1016/j.vaccine.2025.127945
Objectives: Australia expanded access to funded pharmacy vaccination in 2024. We examined changes in the proportion of adult pharmacy-administered vaccination.
Methods: Adult influenza and COVID-19 vaccinations reported in the Australian Immunisation Register from 2023 to 2024 linked to Australian Census socio-demographic information were assessed.
Results: In 2023, 61% of 7.49 million influenza and 54% of 4.61 million COVID-19 vaccinations were provided in general practices, compared to 24% and 44%, respectively, in pharmacies. While total vaccinations declined in 2024 (influenza: 7.04 million; COVID-19: 2.48 million) there was a small increase in pharmacy-administered influenza vaccinations (adjusted odds ratio 1.16 95%CI 1.16-1.17). In both years, a lower proportion of pharmacy-administered vaccinations were given to adults: aged ≥65 years (vs. <65 years); from culturally and linguistically diverse(CALD) backgrounds (vs. non-CALD); with lower incomes, employment and education (vs. higher).
Conclusion: Expanding pharmacy provision of vaccinations may improve uptake, but understanding the impact on under-vaccinated populations is needed.
Keywords: COVID-19; General practice; Influenza; Pharmacy; Vaccination; Vaccine